Fri, Aug 22, 2014, 1:32 PM EDT - U.S. Markets close in 2 hrs 28 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • boilerscamvictim boilerscamvictim Apr 18, 2013 11:41 AM Flag

    Omthera valued at $18 million (better product than Vascepa) AMRN valued at one BILLION??

    Omthera's product is better than Vascepa (has DHA that most docs want) and is cheaper to produce.

    Granted, Epanova will not be proftiable with generic Lovaza on the market either, but the spread here in valuation is insane.

    Nevermind that Vascepa is approved (that was just a "licence to lose money"), Epanova will also be approved (it's just omega-3 produced to API standards people).

    Bottom line is that Omthera's fundamental value is not over $20 million but neither is AMRN's.

    So AMRN must fall 99% + to reflect fundamentals. And it will.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
1.77-0.020(-1.12%)1:31 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.